COMMUNIQUÉS West-GlobeNewswire

Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors
09/10/2024
– Data show that p300 KAT inhibitor KB-9558 was highly selective against human papillomavirus (HPV) oncoproteins E6 and E7, and therefore drove anti-tumor effects – – Poster presentation taking place on Thursday, [...]
Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India
09/10/2024
Sonnet to receive $1.0 million in upfront payment and up to an additional $1.0 million in milestone payments with a royalty in the low double digits on net sales, less certain expenses, in the India market Alkem to fund [...]
Entourage Health Provides Company Update
09/10/2024
TORONTO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company") , a Canadian producer and distributor of award-winning cannabis products, announced [...]
Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit
09/10/2024
MIAMI, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the [...]
SeaStar Medical to Present at the 2024 Maxim Healthcare Virtual Summit
09/10/2024
DENVER, Oct. 09, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on [...]
ENCER Now Available on Amazon: A Game-Changer in Relief from Fatigue Related to Cancer Treatment
08/10/2024
Dr. Yakov Freed, developer of ENCER Photo credit: ENCER DOVER, Del., Oct. 08, 2024 (GLOBE NEWSWIRE) -- ENCER , the groundbreaking homeopathic remedy designed to provide relief from fatigue associated with cancer [...]
Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer
08/10/2024
SALT LAKE CITY, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a series of ongoing research collaborations to study the use [...]
Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit
08/10/2024
SAN JOSE, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and [...]
T2 Biosystems to Host Business Update Call on October 10, 2024
08/10/2024
LEXINGTON, Mass., Oct. 08, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will host a [...]
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024
08/10/2024
PORTLAND, Maine, Oct. 08, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and [...]
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
08/10/2024
SAN DIEGO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
08/10/2024
BOSTON, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases [...]
MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue
08/10/2024
Story Featured Patients Treated with MIMEDX Products MARIETTA, Ga., Oct. 08, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today highlighted the publication of a feature article [...]
Solera Health Unveils New Brand Identity Reflecting the Company's Leadership at the Intersection of Healthcare and Technology
08/10/2024
Rebrand Underscores the Company's Mission to Redefine and Streamline Digital Healthcare Delivery PHOENIX, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Solera Health , a unique technology platform for connecting people seamlessly [...]
Disclosure of notification received from AOC Pharma S.à r.l.
08/10/2024
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 8 October 2024 – 9:00 PM CET Disclosure of notification received from AOC Pharma S.à r.l. Pursuant to the Belgian law of 2 May 2007 regarding the [...]
Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show
08/10/2024
KANSAS CITY, Kan., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Shane J. Schaffer, Chairman and CEO of Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug [...]
Tevogen Bio Highlights Promising Trial Data as CEO Leads Patient Advocacy at Capitol Hill, Pledging to Leverage Multi-Billion Dollar Company Assets to Combat Long COVID and Spearhead a New Wave of Medical Innovation
08/10/2024
The primary study endpoints were related to safety. No dose-limiting toxicities or significant adverse events related to TVGN 489, including Cytokine Release Syndrome, were observed in any patient at any dose level. [...]
Key-Whitman Eye Center Selects Nextech
08/10/2024
Ophthalmology Platform to Automate Clinical Operations TAMPA, Fla., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Nextech, market leader of comprehensive technology solutions for specialty physician practices, today announced Key- [...]
Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Quarter Ended September 30, 2024
08/10/2024
ZTlido net sales for the quarter ended September 30, 2024 were in the range of $11.0 million to $13.0 million, compared to $10.1 million for the same period last year, representing growth in the range of approximately 9 [...]

Pages